A detailed history of Jefferies Financial Group Inc. transactions in Repligen Corp stock. As of the latest transaction made, Jefferies Financial Group Inc. holds 6,888 shares of RGEN stock, worth $859,140. This represents 0.01% of its overall portfolio holdings.

Number of Shares
6,888
Previous 5,288 30.26%
Holding current value
$859,140
Previous $666,000 53.9%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$119.79 - $167.35 $191,664 - $267,760
1,600 Added 30.26%
6,888 $1.03 Million
Q2 2024

Aug 13, 2024

BUY
$120.0 - $182.95 $384,600 - $586,354
3,205 Added 153.86%
5,288 $666,000
Q1 2024

May 13, 2024

BUY
$170.78 - $208.42 $355,734 - $434,138
2,083 New
2,083 $383,000
Q3 2023

Nov 14, 2023

SELL
$138.78 - $176.51 $458,667 - $583,365
-3,305 Reduced 36.41%
5,773 $917,000
Q2 2023

Aug 14, 2023

BUY
$138.42 - $180.31 $1.26 Million - $1.64 Million
9,078 New
9,078 $1.28 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $6.92B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Jefferies Financial Group Inc. Portfolio

Follow Jefferies Financial Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Financial Group Inc. with notifications on news.